Kamata Toshiko 鎌田稔子

… Alternative Names

鎌田稔子カマタトシコ

Less

Researcher Number	60586692
Other IDs
Affiliation (Current)	2025: 国際医療福祉大学, 医学部, 講師 2025: 東京女子医科大学, 医学部, 助教
Affiliation (based on the past Project Information) *help	2021 – 2023: 国際医療福祉大学, 医学部, 助教 2015 – 2016: 東京女子医科大学, 医学部, 助教 2014: 千葉大学, 医学部附属病院, 助教 2013: 千葉大学, 医学部附属病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 55040:Respiratory surgery-related / Respiratory surgery Except Principal Investigator Respiratory surgery
Keywords	Principal Investigator B細胞 / 肺癌 / 免疫チェックポイント阻害剤 / PD-1 / NKT細胞 / 癌免疫治療 / 抗PDL1抗体 / NKT細胞治療 Except Principal Investigator 肺移植 / 再生 / 移植 / 呼吸器外科学

A study on B cell biomarkers associated with checkpoint inhibitors in lung cancerPrincipal Investigator
- Principal Investigator
  
  鎌田稔子
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  International University of Health and Welfare
Development of a novel combination immunotherapy with NKT cells and antibody therapyPrincipal Investigator
- Principal Investigator
  
  Kamata Toshiko
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Respiratory surgery
- Research Institution
  Tokyo Women's Medical University
  Chiba University
Improvement of damaged lung by type II alveolar epithelial cells with multipotency - for the purpose of clinical application of lung transplantation -
- Principal Investigator
  
  Yoshida Shigetoshi
- Project Period (FY)
  2013 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory surgery
- Research Institution
  Chiba Cancer Center (Research Institute)
  Chiba University

All 2023 2016 2015 2014 Other

All Journal Article Presentation

[Journal Article] Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation.2023
- Author(s)
  Matsumoto H, Suzuki H, Yamanaka T, Kaiho T, Hata A, Inage T, Ito T, Kamata T, Tanaka K, Sakairi Y, Motohashi S, Yoshino I.
- Journal Title
  
  Life (Basel)
  
  Volume: 13(10) Issue: 10 Pages: 2042-2042
- DOI
  10.3390/life13102042
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K16521, KAKENHI-PROJECT-23K24441
[Journal Article] Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells.2016
- Author(s)
  Mise N, Takami M, Suzuki A, Kamata T, Harada K, Hishiki T, Saito T, Terui K, Mitsunaga T, Nakata M, Ikeuchi T, Nakayama T, Yoshida H, Motohashi S
- Journal Title
  
  Cancer Science
  
  Volume: 107 Issue: 3 Pages: 233-241
- DOI
  10.1111/cas.12882
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26861119, KAKENHI-PROJECT-24249081, KAKENHI-PROJECT-26462721, KAKENHI-PROJECT-15K10917, KAKENHI-PROJECT-26462705, KAKENHI-PROJECT-16H02778
[Journal Article] Blockade of Programmed Death-1/Programmed Death Ligand pathway enhances the antitumor immunity of human invariant Natural Killer T cells.2016
- Author(s)
  Kamata T, Suzuki A, Mise N, Ihara F, Takami T, Makita Y, Horinaka A, Harada K, Kunii K, Yoshida S, Yoshino I, Nakayama T, and Motohashi S.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 65 Issue: 12 Pages: 1477-1489
- DOI
  10.1007/s00262-016-1901-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24249081, KAKENHI-PROJECT-15K20181, KAKENHI-PROJECT-26861119, KAKENHI-PROJECT-16K19974
[Presentation] Ipilimumab+Nivolumabの治療経験2023
- Author(s)
  鎌田稔子
- Organizer
  I-O combination Therapy in 静岡
- Data Source
  KAKENHI-PROJECT-21K16521
[Presentation] 肺癌に対する免疫チェックポイント阻害剤治療時の自然免疫系の変化と治療効果2023
- Author(s)
  鎌田稔子、吉田成利、和田啓伸、田村　創、中山浩介、本橋新一郎
- Organizer
  第40回日本呼吸器外科学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16521
[Presentation] 原発性肺癌に対するNKT細胞免疫治療と抗PD-1/PD-L1抗体併用療法の有用性2015
- Author(s)
  鎌田稔子、鈴木　茜、吉田成利、吉野一郎、中山俊憲、本橋新一郎
- Organizer
  千葉医学会
- Place of Presentation
  千葉県千葉市
- Year and Date
  2015-02-07
- Data Source
  KAKENHI-PROJECT-26861119
[Presentation] マウス肺全摘モデルを用いた代償性肺成長の解析2015
- Author(s)
  尹　貴正、鈴木秀海、畑敦, 稲毛輝長, 山本高義, 田中教久, 鎌田稔子, 森本淳一, 長門芳, 中島崇裕, 岩田剛和, 吉田成利, 吉野一郎
- Organizer
  第32回日本呼吸器外科学会総会
- Place of Presentation
  サンポートホール高松（香川県・高松市）
- Year and Date
  2015-05-15
- Data Source
  KAKENHI-PROJECT-25462172
[Presentation] Blockade of PD-1/PDL1 in iNKT cell mediated antitumor immunity2015
- Author(s)
  Toshiko Kamata, Akane Suzuki, Naoko Mise, Yuji Makita, Atsushi Horinaka, Naoki Kunii, Shigetoshi Yoshida, Ichiro Yoshino, Toshinori Nakayama, Shinichiro Motohashi
- Organizer
  第44回日本免疫学会学術集会
- Place of Presentation
  札幌コンベンションセンター(北海道札幌市)
- Year and Date
  2015-11-19
- Data Source
  KAKENHI-PROJECT-26861119
[Presentation] Blockade of Programmed Death-1/Programmed Death Ligand pathway enhances the antitumor immunity of human invariant Natural Killer T cells2015
- Author(s)
  Toshiko Kamata, Akane Suzuki, Yuji Makita, Naoki Kunii, Toshinori Nakayama, Shinichiro Motohashi
- Organizer
  第19回日本がん免疫学会総会
- Place of Presentation
  伊藤国際学術研究センター(東京都文京区本郷)
- Year and Date
  2015-07-09
- Data Source
  KAKENHI-PROJECT-26861119
[Presentation] 原発性肺癌に対するNKT細胞免疫療法におけるPD-1阻害の有用性2014
- Author(s)
  鎌田稔子、鈴木茜、藤川陽、三瀬直子、蒔田勇治、吉田成利、鈴木秀海、中島崇裕、岩田剛和、吉野一郎、中山俊憲、本橋新一郎
- Organizer
  日本肺癌学会
- Place of Presentation
  京都府　国立京都国際会館
- Year and Date
  2014-11-15
- Data Source
  KAKENHI-PROJECT-26861119
[Presentation] 原発性肺癌患者における NKT 細胞免疫治療と PD-1 阻害療法の有用性2014
- Author(s)
  鎌田稔子、本橋新一郎、吉田成利、鈴木秀海、中島崇裕、田川哲三、岩田剛和、溝渕輝明、吉野一郎
- Organizer
  日本呼吸器外科学会
- Place of Presentation
  東京都　ホテル日航東京
- Year and Date
  2014-05-29
- Data Source
  KAKENHI-PROJECT-26861119
[Presentation] 肺移植における慢性拒絶反応の病態解明と臨床応用への可能性
- Author(s)
  鈴木秀海、吉田成利、豊田行英、尹　貴正、鎌田稔子、森本淳一、坂入祐一、山田義人、田川哲三、岩田剛和、溝渕輝明、千代雅子、Fan L、Wilkes DS、吉野一郎
- Organizer
  第113回日本外科学会定期学術集会
- Place of Presentation
  福岡
- Data Source
  KAKENHI-PROJECT-25462172
[Presentation] Donor lung derived myeloid and plasmacytoid dendritic cells differentially regulate T cell proliferation and cytokine production
- Author(s)
  Suzuki H, Yoshida S, Sata Y, Inage T, Yun T, Yamamoto T, Kamata T, Morimoto J, Sakairi Y, Nakajima T, Tagawa T, Iwata T, Mizobuchi T, Wilkes DS, Yoshino I.
- Organizer
  The 9th Lung Transplantation Conference
- Place of Presentation
  仙台
- Data Source
  KAKENHI-PROJECT-25462172

1. Yoshida Shigetoshi (90334200)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
2. WADA HIRONOBU (90514604)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. HATA ATSUSHI (30750806)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. MOTOHASHI Shinichiro (60345022)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
5. 坂入祐一 (30551949)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
6. 岩田剛和 (30586681)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
7. 吉野一郎 (40281547)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
8. 鈴木秀海 (60422226)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
9. 田川哲三 (90419557)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
10. 中島崇裕 (20400913)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
11. 山本高義 (20648349)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
12. 尹貴正 (80710491)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
13. SHIINA YUKI

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Kamata Toshiko 鎌田 稔子

鎌田 稔子 カマタ トシコ

Research Projects

Research Products

Co-Researchers

A study on B cell biomarkers associated with checkpoint inhibitors in lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a novel combination immunotherapy with NKT cells and antibody therapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Improvement of damaged lung by type II alveolar epithelial cells with multipotency - for the purpose of clinical application of lung transplantation -

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Blockade of Programmed Death-1/Programmed Death Ligand pathway enhances the antitumor immunity of human invariant Natural Killer T cells.2016

Author(s)

Journal Title

DOI

Data Source

[Presentation] Ipilimumab+Nivolumabの治療経験2023

Author(s)

Organizer

Data Source

[Presentation] 肺癌に対する免疫チェックポイント阻害剤治療時の自然免疫系の変化と治療効果2023

Author(s)

Organizer

Data Source

[Presentation] 原発性肺癌に対するNKT細胞免疫治療と抗PD-1/PD-L1抗体併用療法の有用性2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] マウス肺全摘モデルを用いた代償性肺成長の解析2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Blockade of PD-1/PDL1 in iNKT cell mediated antitumor immunity2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Blockade of Programmed Death-1/Programmed Death Ligand pathway enhances the antitumor immunity of human invariant Natural Killer T cells2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 原発性肺癌に対するNKT細胞免疫療法におけるPD-1阻害の有用性2014

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 原発性肺癌患者における NKT 細胞免疫治療と PD-1 阻害療法の有用性2014

Author(s)

Organizer

Place of Presentation

Kamata Toshiko 鎌田稔子

鎌田稔子カマタトシコ